SweetValueLab
Write for us

The Cooper Companies, Inc. — Intrinsic Value & Fair Price

COO
NASDAQHealthcareMedical - Instruments & SuppliesCIK 0000711404coopercos.comAbout COO
Last close · Oct 16, 202657.94+0.54 (+0.94%)
Market cap$11.0B
Model value · DCF · Perpetuity growth · 5y
51.32
Cooper Companies closed at $57.94 — overvalued by 13% vs model.
28.80the model's range150.52

DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
23.42 – 133.65
Wall St. target
63.50 9% below
Above model, 1y
4 of 20 days

Price and model value

Embed this card

COO's close against its model value, as a 420×168 card for your own page. It updates nightly with this site and links back here.

Free to embed; keep the attribution link.
Loading chart…
What the marks mean
Daily close

Research on COO

No posts on COO yet.
Studied COO from its filings? Guest posts are reviewed before they go live.Write about COO →

How it is valued

Valued asMature & Stable
Low/slowing growth (~7% recent)Moderate margins (9% net margin)Highly cyclical earnings
What growth the price implies: the reverse DCF

Key figures

FY2025
P/E
31.0×
EV / EBITDA
12.7×
FCF yield
3.7%
Dividend yield, TTM
0.00%
Beta
0.82
Cost of capital (WACC)
7.75%
Full financials

Analyst actions

third-party, quoted
10-06Barclays · target60.00
09-10Piper Sandler · “Neutral” from “Overweight”downgrade
09-10William Blair · “Market Perform” from “Outperform”downgrade
09-10Baird · “Neutral” from “Outperform”downgrade
Ratings, targets and estimates

Comparable companies

by business, not by industry label

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just COO. No account.

About Cooper Companies

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

CEO
Albert G. White
Headquarters
San Ramon, CA
Employees
15,000
IPO
1983-01-21
Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.